RxDoctor Payments Data

Sara Lamb, MD

Dermatology · Fort Smith, ARNPI 1376907402

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,647, 7.0 times the $234 reported in 2019. That places this record below the midpoint for dermatology clinicians in AR, where the typical reported total is $3,769.

$2,855in general payments, 2019–2025

Across 106 payments — averaging $26.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$507
  • AbbVie$373
  • Johnson & Johnson$354
  • Arcutis Biotherapeutics, Inc.$243
  • Lilly USA, LLC$225
  • Sanofi$215
  • plus $937 from 15 others

What the payments were for

  • Food & beverage$2,855100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,855 in reported general payments places this provider in the 40th percentile of 75 dermatology providers in Arkansas.

See all dermatology providers in Arkansas

Medicare billing

Part B allowed, 2024
$98,723
Medicare patients
596
Services billed
1,433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab11$129,081
Cosentyx Unoready PenSecukinumab11$97,420
Dupixent PenDupilumab20$70,242
Doxycycline Hyclate41$5,006
Clobetasol Propionate63$1,784
Tacrolimus19$1,766
Metronidazole35$1,761
Fluorouracil23$1,599
Ammonium Lactate61$1,443
Tretinoin15$1,258
Ketoconazole83$1,121
Clindamycin Phosphate23$1,094
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc12$851
ErythromycinErythromycin Base In Ethanol12$651
Doxycycline Monohydrate21$538

Paid to pharmacies, not to this prescriber.

Other dermatology in Fort Smith

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →